I see where you are coming from, but the pharmacy industry doesn't like speculation. Prove you can treat 4 or tell them you can treat 20.
To prove that 20 would take astrinomical funds and trails.
I don't work in a lab, but I get the feeling the indications picked, do also prove a broader range of treatments without actually saying so. But that's my speculation.
Ann: 2023 Results webinar, page-118
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.01 |
Change
0.560(2.74%) |
Mkt cap ! $2.709B | |||
| Open | High | Low | Value | Volume |
| $20.56 | $21.55 | $20.54 | $9.197M | 434.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23 | $21.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.02 | 87 | 9 |
View Market Depth
| Last trade - 14.44pm 16/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |